查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768709

全球介入性肿瘤器材市场

Interventional Oncology Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球介入性肿瘤器材市场规模将达到 39 亿美元

全球介入性肿瘤器械市场规模预计在2024年为27亿美元，到2030年将达到39亿美元，在分析期内（2024-2030年）的复合年增长率为6.4%。栓塞器械是本报告分析的细分市场之一，预计其复合年增长率为7.3%，到分析期结束时规模将达到24亿美元。消融器械细分市场在分析期间内的复合年增长率预计为5.3%。

美国市场规模估计为 7.041 亿美元，中国市场预计复合年增长率为 9.6%

美国介入性肿瘤器械市场规模预计2024年达到7.041亿美元。作为世界第二大经济体，中国预计在2024-2030年的分析期间内实现9.6%的复合年增长率，到2030年市场规模将达到9.156亿美元。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.4%和5.7%。在欧洲，预计德国的复合年增长率为3.9%。

全球介入性肿瘤设备市场－主要趋势与驱动因素摘要

介入性肿瘤设备如何推动癌症治疗？

介入性肿瘤器械正在彻底改变癌症治疗，它透过提供微创手术来精准靶向肿瘤，同时减少对传统手术的需求并最大限度地减少对周围组织的损伤。这些器械用于影像导引手术，例如射频消融 (RFA)、微波消融 (MWA) 和经动脉化疗栓塞 (TACE)，将标靶治疗直接递送至肿瘤。介入性肿瘤治疗越来越多地应用于肝癌、肺癌、肾癌和骨癌，为患者提供了一种比开放性手术更安全、创伤更小的治疗方法治疗方法。这些技术正在提高存活率并缩短復原时间，为不适合传统手术的患者带来新的希望。

哪些技术创新正在推动介入肿瘤学的发展？

显像模式、机器人技术和消融技术的进步正在推动介入肿瘤学的发展。包括核磁共振成像 (MRI)、电脑断层扫描 (CT) 和超音波在内的影像技术的创新，使得在治疗过程中能够即时、高解析度地可视化肿瘤，从而提高治疗的精准度和安全性。机器人系统正在提高介入的精准度，从而能够更好地瞄准难以触及部位的肿瘤。新的消融技术，包括微波消融和冷冻消融，正在提供更有效的肿瘤摧毁方法，同时最大限度地减少对健康组织的伤害。这些进步正在扩展介入肿瘤学的能力，使其能够治疗更广泛的癌症。

市场区隔将如何定义介入性肿瘤设备的成长？

器械类型包括消融器械、栓塞器械和支持器械，其中消融器械占据市场主导地位，因其广泛用于微创肿瘤破坏。相关手术包括射频消融、微波消融和经动脉化疗栓塞，其中微波消融因其在治疗较大肿瘤方面的高效性而日益普及。介入性肿瘤器械治疗的癌症类型包括肝癌、肺癌、肾癌和骨癌，其中肝癌是最大的治疗领域，因为肝细胞癌的发生率较高。由于先进的医疗基础设施和微创治疗的日益普及，北美和欧洲等地区的微创治疗市场正在显着成长。

哪些因素推动了介入性肿瘤设备市场的成长？

介入性肿瘤器械市场的成长受到多种因素的推动，例如癌症发病率的上升、人们对微创治疗的日益偏好以及影像和消融技术的进步。随着全球癌症发生率的上升，对更多微创和标靶治疗方案的需求也日益增长。介入性肿瘤学透过提供对患者创伤更小、可更快康復的治疗方案，提供了一种解决方案。即时成像和精准消融领域的技术创新，透过提高这些治疗的有效性和安全性，进一步推动了市场的成长。此外，由于医疗基础设施的改善和先进医疗技术的普及，新兴市场对介入性肿瘤学的采用日益增多，也促进了市场的扩张。

部分

设备（栓塞设备、消融设备、支援设备）、癌症类型（肝癌、乳癌、肺癌、肾癌、摄护腺癌、其他癌症类型）

受访公司范例

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • CR Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS SA
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP22106

Global Interventional Oncology Devices Market to Reach US$3.9 Billion by 2030

The global market for Interventional Oncology Devices estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Ablation Devices segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.1 Million While China is Forecast to Grow at 9.6% CAGR

The Interventional Oncology Devices market in the U.S. is estimated at US$704.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$915.6 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Interventional Oncology Devices Market - Key Trends and Drivers Summarized

How Are Interventional Oncology Devices Advancing Cancer Treatment?

Interventional oncology devices are revolutionizing cancer treatment by offering minimally invasive procedures that target tumors with precision, reducing the need for traditional surgery and minimizing damage to surrounding tissues. These devices are used in image-guided procedures such as radiofrequency ablation (RFA), microwave ablation (MWA), and transarterial chemoembolization (TACE), which deliver targeted therapies directly to tumors. Interventional oncology treatments are increasingly being adopted for liver, lung, kidney, and bone cancers, providing patients with safer, less invasive alternatives to open surgery. These technologies are improving survival rates, reducing recovery times, and offering new hope to patients who may not be candidates for traditional surgery.

What Technological Innovations Are Driving Interventional Oncology?

Technological advancements in imaging modalities, robotics, and ablation techniques are driving the growth of interventional oncology. Innovations in imaging technologies, such as MRI, CT, and ultrasound, are enabling real-time, high-resolution visualization of tumors during procedures, improving the accuracy and safety of treatments. Robotic systems are enhancing the precision of interventions, allowing for better targeting of tumors in hard-to-reach areas. New ablation techniques, including microwave ablation and cryoablation, are providing more effective options for tumor destruction while minimizing damage to healthy tissues. These advancements are expanding the capabilities of interventional oncology and allowing for the treatment of a broader range of cancers.

How Do Market Segments Define the Growth of Interventional Oncology Devices?

Device types include ablation devices, embolization devices, and support devices, with ablation devices leading the market due to their widespread use in minimally invasive tumor destruction. Procedures include radiofrequency ablation, microwave ablation, and transarterial chemoembolization, with microwave ablation gaining popularity due to its higher efficacy in treating larger tumors. Cancer types treated with interventional oncology devices include liver, lung, kidney, and bone cancers, with liver cancer being the largest segment due to the high prevalence of hepatocellular carcinoma. The market is growing significantly in regions such as North America and Europe, driven by the availability of advanced healthcare infrastructure and the increasing adoption of minimally invasive treatments.

What Factors Are Driving the Growth in the Interventional Oncology Devices Market?

The growth in the interventional oncology devices market is driven by several factors, including the increasing incidence of cancer, the growing preference for minimally invasive treatments, and advancements in imaging and ablation technologies. As cancer rates rise globally, demand for less invasive and more targeted treatment options is increasing. Interventional oncology offers a solution by providing procedures that are less traumatic for patients and offer faster recovery times. Technological innovations in real-time imaging and precision ablation are further driving market growth by improving the effectiveness and safety of these treatments. Additionally, the rising adoption of interventional oncology in emerging markets, driven by improving healthcare infrastructure and access to advanced medical technologies, is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Interventional Oncology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Embolization Devices, Ablation Devices, Support Devices); Cancer Type (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Other Cancer Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Interventional Oncology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Growth in the Interventional Oncology Devices Market
    • Technological Advancements in Image-Guided Cancer Treatment Strengthen Demand for Interventional Devices
    • Growing Use of Minimally Invasive Procedures Fuels Adoption of Interventional Oncology Devices
    • Expansion of Radiofrequency Ablation and Cryoablation Techniques Drives Market Growth
    • Rising Focus on Targeted Cancer Therapies Expands Addressable Market for Interventional Devices
    • Technological Innovations in Microwave Ablation and Embolization Techniques Propel Market Growth
    • Increasing Adoption of Interventional Oncology in Liver, Lung, and Kidney Cancer Treatment Strengthens Market
    • Focus on Reducing Patient Recovery Time and Treatment Side Effects Fuels Demand for Minimally Invasive Solutions
    • Rising Demand for Image-Guided and Navigation-Assisted Cancer Therapies Expands Market Potential
    • Technological Advancements in Catheter-Based Delivery Systems Propel Growth in Interventional Oncology Devices
    • Increasing Focus on Palliative Care and Symptom Management in Cancer Patients Expands Market Opportunities
    • Rising Awareness of Early Cancer Detection and Treatment Options Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lung cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Interventional Oncology Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • INDIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AFRICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030

IV. COMPETITION